Atyr Pharma Inc logo

Atyr Pharma Inc Share Price (NASDAQ: LIFE)

▲

-1.9

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 4 Jun 2024

Check the interactive Atyr Pharma Inc Stock chart to analyse performance

Atyr Pharma Inc Key Stats

Check Atyr Pharma Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.9
Open
$1.86
Market Capitalization
$131.1M
Today's Volume
$268.9K
Revenue TTM
$588.0K
EBITDA
$-58.1M
Earnings Per Share (EPS)
$-0.88
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-55.61%

Global Institutional Holdings in Atyr Pharma Inc

  • Name

    Holdings %

  • Federated Hermes Inc

    14.74%

  • FMR Inc

    12.93%

  • Logos Global Management LP

    4.49%

  • Vanguard Group Inc

    3.84%

  • Tikvah Management LLC

    3.57%

  • Woodline Partners LP

    2.44%

Analyst Recommendation on Atyr Pharma Inc Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Atyr Pharma Inc(by analysts ranked 0 to 5 stars)

About Atyr Pharma Inc

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Organization
Atyr Pharma Inc
Employees
56
CEO
Dr. Sanjay S. Shukla M.D., M.S.
Industry
Health Technology

Important FAQs about investing in LIFE Stock from India :

What is Atyr Pharma Inc share price today?

Atyr Pharma Inc share price today is as on at the close of the market. Atyr Pharma Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Atyr Pharma Inc share?

Atyr Pharma Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Atyr Pharma Inc stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Atyr Pharma Inc Stock (LIFE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atyr Pharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atyr Pharma Inc Shares .

What is the minimum amount required to buy Atyr Pharma Inc Stock (LIFE) from India?

Indian investors can start investing in Atyr Pharma Inc (LIFE) shares with as little as ₹89.35 or $1 (as of November 22, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹893.50 in Atyr Pharma Inc stock (as per the Rupee-Dollar exchange rate as on November 22, 2025). Learn more about fractional shares .

What are the returns that Atyr Pharma Inc has given to Indian investors in the last 5 years?

Atyr Pharma Inc stock has given 0.0% share price returns and 20.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?

Discover More

Explore all